These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37735473)

  • 1. The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG.
    Kugler E; Madiwale S; Yong D; Thoms JAI; Birger Y; Sykes DB; Schmoellerl J; Drakul A; Priebe V; Yassin M; Aqaqe N; Rein A; Fishman H; Geron I; Chen CW; Raught B; Liu Q; Ogana H; Liedke E; Bourquin JP; Zuber J; Milyavsky M; Pimanda J; Privé GG; Izraeli S
    Nat Commun; 2023 Sep; 14(1):5871. PubMed ID: 37735473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANK ligand converts the NCoR/HDAC3 co-repressor to a PGC1β- and RNA-dependent co-activator of osteoclast gene expression.
    Abe Y; Kofman ER; Almeida M; Ouyang Z; Ponte F; Mueller JR; Cruz-Becerra G; Sakai M; Prohaska TA; Spann NJ; Resende-Coelho A; Seidman JS; Stender JD; Taylor H; Fan W; Link VM; Cobo I; Schlachetzki JCM; Hamakubo T; Jepsen K; Sakai J; Downes M; Evans RM; Yeo GW; Kadonaga JT; Manolagas SC; Rosenfeld MG; Glass CK
    Mol Cell; 2023 Oct; 83(19):3421-3437.e11. PubMed ID: 37751740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Transcription Factor ERG Regulates Super-Enhancers Associated With an Endothelial-Specific Gene Expression Program.
    Kalna V; Yang Y; Peghaire CR; Frudd K; Hannah R; Shah AV; Osuna Almagro L; Boyle JJ; Göttgens B; Ferrer J; Randi AM; Birdsey GM
    Circ Res; 2019 Apr; 124(9):1337-1349. PubMed ID: 30892142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia.
    Goldberg L; Tijssen MR; Birger Y; Hannah RL; Kinston SJ; Schütte J; Beck D; Knezevic K; Schiby G; Jacob-Hirsch J; Biran A; Kloog Y; Marcucci G; Bloomfield CD; Aplan PD; Pimanda JE; Göttgens B; Izraeli S
    Blood; 2013 Oct; 122(15):2694-703. PubMed ID: 23974202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC3 ensures stepwise epidermal stratification via NCoR/SMRT-reliant mechanisms independent of its histone deacetylase activity.
    Szigety KM; Liu F; Yuan CY; Moran DJ; Horrell J; Gochnauer HR; Cohen RN; Katz JP; Kaestner KH; Seykora JT; Tobias JW; Lazar MA; Xu M; Millar SE
    Genes Dev; 2020 Jul; 34(13-14):973-988. PubMed ID: 32467224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
    Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
    Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR screen identifies the NCOR/HDAC3 complex as a major suppressor of differentiation in rhabdomyosarcoma.
    Phelps MP; Bailey JN; Vleeshouwer-Neumann T; Chen EY
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15090-15095. PubMed ID: 27956629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NCoR Co-repressor Interacts with the Kaiso Transcription Factor through a Mechanism Different from That of BCL6 Interaction.
    Balagurov KI; Georgiev PG; Bonchuk AN
    Dokl Biochem Biophys; 2022 Dec; 507(1):326-329. PubMed ID: 36786995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).
    Ichikawa H; Shimizu K; Katsu R; Ohki M
    Mol Cell Biol; 1999 Nov; 19(11):7639-50. PubMed ID: 10523652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mus musculus papillomavirus 1 E8^E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation
    Kuehner F; Wong M; Straub E; Doorbar J; Iftner T; Roden RBS; Stubenrauch F
    mBio; 2023 Aug; 14(4):e0069623. PubMed ID: 37382436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.
    Xie Y; Koch ML; Zhang X; Hamblen MJ; Godinho FJ; Fujiwara Y; Xie H; Klusmann JH; Orkin SH; Li Z
    Stem Cells; 2017 Jul; 35(7):1773-1785. PubMed ID: 28436588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncogene ERG: a key factor in prostate cancer.
    Adamo P; Ladomery MR
    Oncogene; 2016 Jan; 35(4):403-14. PubMed ID: 25915839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Expression of Proto-Oncogene
    Khosh Kish E; Choudhry M; Gamallat Y; Buharideen SM; D D; Bismar TA
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion and maintenance of leukemia by ERG.
    Tsuzuki S; Taguchi O; Seto M
    Blood; 2011 Apr; 117(14):3858-68. PubMed ID: 21321361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of NCOR/SMRT Repressor Complexes with Papillomavirus E8^E2C Proteins Inhibits Viral Replication.
    Dreer M; Fertey J; van de Poel S; Straub E; Madlung J; Macek B; Iftner T; Stubenrauch F
    PLoS Pathog; 2016 Apr; 12(4):e1005556. PubMed ID: 27064408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
    Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
    Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Evolutionarily Conserved Cassette Exon 7b Drives ERG's Oncogenic Properties.
    Jumbe SL; Porazinski SR; Oltean S; Mansell JP; Vahabi B; Wilson ID; Ladomery MR
    Transl Oncol; 2019 Jan; 12(1):134-142. PubMed ID: 30296658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERG is a megakaryocytic oncogene.
    Salek-Ardakani S; Smooha G; de Boer J; Sebire NJ; Morrow M; Rainis L; Lee S; Williams O; Izraeli S; Brady HJ
    Cancer Res; 2009 Jun; 69(11):4665-73. PubMed ID: 19487285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of HDAC3 to transcriptional repression by the human papillomavirus 31 E8^E2 protein.
    Dreer M; Blondzik S; Straub E; Iftner T; Stubenrauch F
    J Gen Virol; 2020 Jul; 101(7):751-759. PubMed ID: 32421493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.
    Tracey LJ; Brooke-Bisschop T; Jansen PWTC; Campos EI; Vermeulen M; Justice MJ
    Mol Cancer Res; 2019 Jul; 17(7):1468-1479. PubMed ID: 31015254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.